Publication: 2163

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
      QxMD      Google Scholar   
Citation:
Breast Cancer Res Treat vol 117 (3) 603-609
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
   
Pharmas:
 
Grants:
CA 124477, N01 CA035431, U10 CA035269, CA-37404, K05 CA124477, U10 CA037404, CA-35103, CA-25224, U10 CA035415, CA-35415, U10 CA035431, CA-35269, U10 CA025224, U10 CA035103  
Corr. Author:
 
Authors:
                           
Networks:
 
Study
NCCTG-N03CC
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Breast cancer, Aromatase inhibitor, Bone loss, Zoledronic acid